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ABSTRACT

Introduction: Medical providers may not be familiar with the genitourinary and sexual symptoms of transgender
and non-binary (TGNB) individuals. This lack of familiarity may hinder a provider’s ability to address these issues as
patients may hesitate to report symptoms due to fear of stigma, misgendering, and being treated disrespectfully.
Aim: To describe the array of genitourinary and sexual symptoms in transfeminine individuals.
Methods: Upon institutional review board approval, researchers used semi-structured interviews with 25 transfeminine individuals assigned male at birth to explore urinary and sexual symptoms on a sample of convenience.
Participants were recruited and interviews were conducted until saturation was achieved. Two research assistants
independently coded all de-identiﬁed transcripts and resolved discrepancies.
Outcomes: Thematic codes pertaining to genitourinary and sexual symptoms were deﬁned and assessed in this study.
Results: Some genitourinary symptoms unrelated to hormone therapy or genital gender-afﬁrming surgery
(GGAS) included frequency, urgency, nocturia, and incontinence, while those attributed to GGAS included
slow stream, spraying, and retention. Sexual symptoms unrelated to hormone therapy or GGAS included sexually
transmitted infections, erectile dysfunction, and low libido. Sexual symptoms related to GGAS included delayed
ejaculation, penile pain, scar tissue pain, and pain with receptive vaginal penetration.
Clinical Implications: Increased provider awareness of and accountability for the treatment of genital and sexual
symptoms of transfeminine individuals.
Strengths and Limitations: Open-ended questions were used to generate a range of responses and perspectives
through conversation instead of quantiﬁable data. Findings are not applicable to all TGNB people since participants
were limited to transfeminine adults assigned male at birth only. Recruitment was limited by the sensitive nature of the
topic and hard-to-reach populations and relied on convenience through ﬂyers and a chain-referral sampling approach.
Conclusion: Transfeminine individuals experience a wide array of genitourinary and sexual symptoms both similar and different to their cis gender counterparts. Chung PH, Swaminathan V, Spigner S, et al. Genitourinary
and Sexual Symptoms and Treatments in Transfeminine Individuals: A Qualitative Exploration of
Patients’ Needs. Sex Med 2022;XX:XXXXXX.
Copyright © 2022 The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual
Medicine. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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INTRODUCTION
Approximately 1 million individuals 18 years of age and older
identify themselves as transgender or nonbinary (TGNB) in the
United States based on population-based probability samples
analyzed in 2016, with this number increasing every year.1 It is
well documented that these individuals have decreased access to
care, are often denied care, and commonly suffer from negative
1

2

health care experiences.2-5 Recent studies have shed light on the
underlying causes, which include in part a lack of providers’ with
sufﬁcient TGNB health knowledge.4 Regardless of a physicians’
welcoming nature or sensitivity, survey participants often report
that physicians do not know enough about the speciﬁc health
issues and treatment provisions speciﬁc to the TGNB community to provide adequate care.4,5
Patients from the TGNB community may have sensitive
symptoms (ie, genitourinary and sexual) which may be difﬁcult
to discuss with a provider. TGNB individuals may also have
increased difﬁculty discussing such sensitive issues when they
relate to their anatomy.6 Primarily, TGNB adults attempting to
access care face signiﬁcant barriers when there is a scarcity of
knowledgeable and well-informed physicians.7-11 Providers in
turn may not be aware or may not feel comfortable inquiring
about such symptoms, leaving them unaddressed.12 Providers
need to be able to adequately, appropriately, and respectfully
identify these symptoms and create a space wherein these
patients feel free to describe the nuances of their conditions.
A lack of provider education in TGNB care may contribute to
missed opportunities in addressing issues during patient encounters.13 Increased provider exposure to TGNB needs may pave
the way for improved care.14 In this study, we aim to describe
the array of genitourinary and sexual symptoms in transfeminine
(TGNB individuals assigned male at birth) individuals in a qualitative manner. A qualitative approach was utilized to elicit an
array of deeper insights into the experiences, behaviors, and attitudes of participants, which may otherwise be difﬁcult to capture
with quantitative techniques. Since genitourinary and sexual
symptoms of TGNB are not well described, this approach will
help to identify the sensitive issues that can then be translated
into a quantitative study. Information gathered from this study
will also be utilized to guide the development of a questionnaire
which assesses relevant genitourinary and sexual symptoms
within the TGNB community.

MATERIALS AND METHODS
Study Design
This Health Insurance Portability and Accountability Act
(HIPAA)-compliant study received institutional review board
approval (19D.006). We present our article in accordance with
the Consolidated Criteria for Reporting Qualitative Research
(COREQ).15 A qualitative approach was selected to allow participants to express themselves and provide ﬁrst-hand documentation of experiences while providing data on sensitive issues.
Semi-structured interviews were conducted using an interview
guide of open-ended questions designed to elicit a range of
responses rather than quantiﬁable data about genitourinary and
sexual symptoms and relationships with and openness of disclosing symptoms to health care providers (Appendix 1). The interview guide was informed by the literature and Andersen’s
Model, a framework commonly employed to explore health care

Chung et al

utilization among underserved and marginalized persons.16,17
The team developed and piloted the guide, and minor modiﬁcations were made after the ﬁrst 10 interviews were completed and
reviewed. When data collection was completed, the team conducted a content analysis of interview transcripts. The details of
our study have been previously described, with use of similar
methodologies and sample patient population.2 Brieﬂy, thematic
codes were developed using directed content analysis in 2 ways: a
priori (informed by the literature and interview guide) and
through line-by-line reading of a subsample of interview transcripts.18 Each code was given an explicit deﬁnition to ensure
coding accuracy and improve intercoder reliability.

Data Acquisition
Twenty-ﬁve transfeminine participants assigned male at birth
ages 18 and older were recruited from May 2019 to July 2019.
Flyers detailing our research project were posted at our outpatient urology clinic and community centers frequented by
TGNB adults to recruit patients. Some of the participants were
patients of the principal investigator (PC) and freely participated
in the study because of their desire to help advance LGBTQ+
care. A snowball or chain-referral sampling approach, a technique
used when researching hard-to-reach populations or sensitive
topics, was also employed within the general community and
clinical setting to increase sample size.19 Participants provided
informed verbal consent and participated in audio recorded telephone interviews with SS at a designated research workplace,
which lasted approximately 60 minutes. During the study
period, SS was a full-time student completing her degree in Master of Public Health who underwent speciﬁc qualitative research
and interview training and received guidance from a qualitative
research expert (RF) with over 20 years of experience. As is common in qualitative research, the interview guide was reviewed
and modiﬁed following early interviews to improve data collection throughout the study.20
Demographic data including patient age, identity, pronouns
and whether they had undergone genital gender-afﬁrming surgery (GGAS) were queried. Follow-up interviews were not performed. Participants did not provide feedback on the transcripts
or ﬁndings of this study. Transcriptions were deidentiﬁed and
reviewed by the team (SS and VS) to check for accuracy. Participants received a $40 gift card as compensation.

Coding and Statistical Analysis
A constant-comparison approach, commonly used when conducting content analysis, was used to evaluate earlier interviews
before conducting later interviews. A total of 25 people were
interviewed, which was a sufﬁcient sample size to achieve thematic saturation, meaning that later interviews did not generate
new codes.20,21 A code book (Appendix 2) was developed using
directed content analysis as informed by the literature and interview guide and through reading of a subsample of transcripts.18
Sex Med 2022;10:100566
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Each code was given a clear deﬁnition to improve intercoder reliability and ensure coding accuracy.21 SS and VS coded all transcripts independently. Coding and analysis were performed with
NVivo software (version 12, QSR International, Melbourne,
Australia). k coefﬁcient was calculated to determine intercoder
reliability to improve communicability, systematicity and transparency of the coding process.22,23 Upon completion of coding,
reports were reviewed, and ﬁndings were organized into thematic
categories by team consensus. Participant quotations are presented to illustrate these ﬁndings.

RESULTS
Twenty-ﬁve transfeminine individuals with a mean age of 36
(range 23−67) years completed an interview. No participants
dropped out during or after the study period. Of these, 12 participants reported having undergone GGAS, 16 were on hormone
therapy, (eg, estradiol or anti-androgens), and 7 reported both
having undergone GGAS and remained on hormone therapy.
Intercoder reliability analysis revealed near-perfect agreement
between coders (mean k = 0.99; range k = 0.71−1.00). This
result was supported by percentage of agreement analysis, which
yielded a mean of 99.9% (range 95%−100%) agreement of all
codes. This indicates that the coding frame allows for communicability across coders. Responses were broadly classiﬁed into 3
categories for analysis: genitourinary symptoms, sexual symptoms, and successful relationships with providers. Representative
participant responses for each category are exhibited in Table 1.
Genitourinary Symptoms − Participants both with and without a history of hormone therapy or GGAS reported genitourinary symptoms. Common genitourinary issues reported by both
groups included urge incontinence, stress incontinence, urinary
retention, and recurrent urinary tract and prostate infections.
Spraying of urine, dysuria, and varicoceles were also noted. Several patients were frustrated that they had to learn about urinary
side effects from hormone therapy (ie, spironolactone) through
their own research and experience rather than through education
from a provider. Participants who had undergone gender-reafﬁrming surgical intervention reported urethral strictures and
external scar tissue restricting urine outﬂow, loss of sensation,
and chronic pain in the genital region as post-procedure symptoms.
Sexual Symptoms − Participants both with and without a history of hormone therapy or GGAS reported sexual symptoms.
Respondents described both their penis or vagina as being important for sexual function. Most participants, regardless of whether
treated with hormone therapy, reported symptoms of lowered
libido, anorgasmia, and erectile dysfunction. Pain in the genital
and perineal region during sexual encounters and delayed ejaculation were common issues encountered by participants who did
undergo hormone therapy or GGAS. In addition, several participants reported seeking psychological care due to distress from
inadequate sexual performances.
Sex Med 2022;10:100566

Successful Relationships with Providers − Participants described
the characteristics of a productive provider-patient relationship
when visiting providers for genitourinary and sexual symptoms.
It was detailed how a single provider may not encompass and
treat all conditions a patient may experience, and thus additional
ancillary care may be needed as a holistic approach to treatment.
For example, although one patient described a strong relationship with their urologist with regards to their GGAS and hormone therapy, they described the need for physical therapy to
strengthen pelvic ﬂoor function. Patients also valued providers
who had expertise and additional training speciﬁcally in the care
of TGNB patients, as they reported lower rates of misgendering
and discrimination in these instances. They stated that seeing
TGNB knowledgeable physicians encouraged them to speak
more about their genitourinary and sexual symptoms. Some participants pointed to a lack of provider knowledge and poor provider-patient communication in their care as a reason for
avoidance of care.

DISCUSSION
As the number of TGNB individuals presenting as patients
continues to increase, providers will beneﬁt from an improved
understanding of the bothersome genitourinary and sexual symptoms that TGNB may present with. Prior investigations have
revealed that providers lack sufﬁcient training, speciﬁcally with
regards to these domains.3 In this study, transfeminine individuals detailed many genitourinary and sexual symptoms, including
sequelae that present after hormone therapy and/or GGAS.
These participants also conﬁrmed the conclusions of the literature, stating that poor provider understanding of these urological
problems and communicative barriers play a part in some reluctance to seek treatment.
For proper education and subsequent clinical treatment of
common genitourinary and sexual symptoms experienced by the
TGNB population, medical providers will beneﬁt from listening
to members of said population with regards to the issues they
most commonly face. Some of these symptoms may be a result
of hormone therapy or GGAS, while other issues may persist
regardless of treatment status. It is important that urologists recognize that transfeminine individuals do not always present
requesting or have even undergone urology-related transition
care. Many individuals seek care from urologists for routine urological issues such as, urological cancer screening and interventions, urolithiasis, voiding dysfunction, and erectile dysfunction.
With regards to genitourinary symptoms speciﬁcally, various
forms of incontinence and retention, along with variations in
one’s urine stream with regards to force and spray were the main
issues faced by respondents regardless of their intervention status.
One participant stated, “I will not be able to hold when I need to
pee, and then after I pee, I'll sit there for a few minutes. I'll think
it's completely done, but inevitably, after I stand up, there's still
something that comes out, and it causes some minor problems. I
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Table 1. Representative participant responses.
Genitourinary Symptoms

Sexual Symptoms

Successful Relationships
with Providers

 “When I take [spironolactone], I know that I need to pee a lot more and my like retention is like not as
good and you're getting up in the middle of the night to go to the restroom.”
 “I was saying about the. . .urine being stuck in the urethra and no matter how much you pee or how
much you drink water, it's never going to go away. So you always have the feeling to pee and just
forcing you know or drinking more water, it just makes the urge really more irritating.”
 “I will not be able to hold when I need to pee, and then after I pee, I'll sit there for a few minutes. I'll
think it's completely done, but inevitably, after I stand up, there's still something that comes out, and
it causes some minor problems. I haven't really spoken to anybody about it.”
 “My erection has been softer since I've been on hormones and since the orchiectomy I've noticed a lot
of pain at the shaft, the base of the shaft. . .I feel like the scar tissue pain.”
 “Since transitioning I have been pretty sexually inactive. Because estrogen has killed my libido.”
 “I've had a history of dealing with hemorrhoids and if I have an anal fissure that's come and go, but
since the surgery, it's been quite consistent that after sex I'll have. . .terrible, terrible hemorrhoids and
fissures flare up afterwards.”
 “I feel really. . .inadequate. . .we used to have sex a lot. . .in the beginning stages of my transitioning
and it just kind of has fizzled, and I think that's just been a little disappointing, for me especially
because. . .I don't know what to do.”
 “Since I had my gender confirmation surgery, I guess it's because of the healing process that it's not
over yet. I've had some pain when muscles tense and when I'm aroused. So, it has been, I have to say
that it has been uncomfortable.”
 “The care provider sort of admitted that. . .they weren't an expert on this and that they weren't totally
sure that what they were saying was true. . .it was nice that they admitted that, but was you know
just not very like encouraging.”
 “Most people don't know the least bit how to treat us. They seem to think that because I'm trans a
sinus infection is different in me than it is in somebody else. If I wind up talking to them at all about
what the surgeries I've had most of them just have no clue about anything to do with any of it.”
 “It's probably been a decade since I've seen a gynecologist because I don't know any gynecologists
with expertise in dealing with trans women. The last time I went to a gynecologist he went down with
a speculum, took a look at me, and said everything looked normal, and took a swab to send off for a
pap smear. I had to tell him that I was postop trans sexual, and that I don't have a cervix.”
 “Even at places that specialize in trans care, they simply don't know what's going to happen and
they're still learning. I feel like I've been asked a lot and it's great that again, they trust me, in terms of
how to handle my HRT therapy, but they don't really have answers in terms of what's going to work.”

haven't really spoken to anybody about it.” Prior studies have
detailed how speaking about these issues may be a sensitive topic,
and that providers must be gentle when initiating a conversation.24 Furthermore, a subset of these urinary symptoms may be
explained by obstacles faced by patients in a social setting. Published literature has found that avoidance of gendered public restrooms due to feelings of discrimination may cause subjective
reports of “weak bladders.”21
Genital pain and urethral scarring were also commonly
reported urological issues encountered by transfeminine individuals who pursued GGAS. With surgical interventions such as
phalloplasty and vaginoplasty carrying complication rates up to
51% and 20%−70%, respectively, surgeons will beneﬁt from
surgery study to lower the rates of complications.25,26 Rather
than allowing patients to dismiss these symptoms as a risk of
GGAS, further studies into the mechanics and techniques for
such procedures will better serve the population. This can only
happen when patients feel free to openly discuss their symptoms.
The Transgender and Non-Binary − Allied Research Collective
(TRANS-ARC), led by advocates, trans community members,
researchers, and clinicians, is leading an initiative to learn directly

from stakeholders on how to improve surgical care and
outcomes.27
When analyzing sexual symptoms experienced by respondents, lowered libido and pain during sexual intercourse were
the most common symptoms experienced. Although published literature exists to support the incidence of lowered
levels of sexual desire among individuals that identify as
transfeminine, many of the interviewee’s phrased their realization of this symptom as something not clearly detailed to
them.28-30 Members of the transfeminine population may
perceive deterioration in sexual function as an eventuality
rather than a treatable condition.6 Providers also need to recognize that patients may remain interested in engaging in
sexual activity with their natal anatomy despite identifying as
transfeminine. One participant stated, “My erection has been
softer since I've been on hormones” while another reported
“Since transitioning I have been pretty sexually inactive.
Because estrogen has killed my libido.” Other symptoms like
dyspareunia experienced by respondents are consistent with
documented literature and require further clinical work-up
by the provider to develop a personalized treatment plan.31,32
Sex Med 2022;10:100566
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A strong patient-provider relationship was often quoted to be
of great importance when addressing the genitourinary and sexual symptoms experienced by respondents. This is consistent
with prior literature, which details how experiences of misgendering, the need to educate physicians on patient experiences, and
the degree of compassion expressed by a urologist were all factors
that contributed to the success of seeking care by transfeminine
patients.33 While compassion is imperative, knowledge is equally
important. One participant stated, “the care provider sort of
admitted that. . .they weren't an expert on this and that they
weren't totally sure that what they were saying was true. . .it was
nice that they admitted that, but was you know just not very like
encouraging.” Additionally, the claim by some respondents stating that more individuals would seek care for their genitourinary
and sexual symptoms given access to more culturally competent
physicians is supported by studies showing the same.34 This supports the possibility that rather than solely educating future clinicians about the clinical signs and symptoms important to this
population, the medical community should embrace further
teachings regarding proper communication skills towards the
transfeminine in particular as well in an effort to increase trust in
health care.35
Our study should be interpreted in the context of several limitations. TGNB stakeholders were not involved in the study
design or interview guide development. Therefore, important
questions and issues relevant to the community may have been
overlooked. However, a qualitative approach and open-ended
questions were utilized to generate a range of responses and perspectives through conversation to capture the experiences of the
participants instead of quantiﬁable data. We have developed a
questionnaire based on these inputs from stakeholders which we
will utilize to quantify symptoms in a future study. Findings are
not applicable to all TGNB people since participants were limited to transfeminine adults only. Recruitment was limited by
the sensitive nature of the topic and hard-to-reach populations
and relied on convenience through ﬂyers and a chain-referral
sampling approach from the general community and clinic setting. Despite these limitations, we have achieved the intent of
the study, to shed light on the experiences of this demographic
and open the door for quantiﬁable and generalizable studies in
the future.

CONCLUSION
Transfeminine individuals experience a wide array of
genitourinary and sexual symptoms both similar and different to their cis gender counterparts. Shedding light on a
representation of common symptoms may foster awareness
among providers and better care for this patient population.
We hope that this study can provide an education and
understanding of the spectrum of symptoms that transfeminine individuals may experience, regardless of medical or
surgical therapy.
Sex Med 2022;10:100566
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A Qualitative Exploration of Patients’ Needs

APPENDIX 1: INTERVIEW GUIDE
A Qualitative Study of the Transgender Patient Experience in
the Urology Setting
My name is Sabina Spigner and I am a research assistant
working at Thomas Jefferson University with Dr. Paul Chung
who is a urologist who deals with the urinary system. We are
speaking to you today because we are trying to identify barriers
to care for transgender women. We are interested in gaining a
better understanding of your experiences and thoughts about
health care, in particular with respects to urology.
There are no right or wrong answers because everyone has different ideas and experiences. We are interested in the full range
of experiences, so please share your honest point of view. We are
here to learn. Is this still a good time to talk? This is going to
take between 30 and 50 minutes - do you have that time?
Your participation in this study is voluntary and you can stop
our conversation at any time. Your name will not be connected
to anything we discuss today. With your permission I will record
our conversation, the recording will be transcribed and after that
the recording will be deleted. No one knows that you volunteered to talk to me today and I’m not going to reveal your
name. Do you have any questions?
Are you ready to begin? Do I have your permission to turn on
the recorder?
Ask demographics: Age, identity, pronouns, surgery
(i) Take a minute to think about your past health care visits.
a) When thinking about these visits, what are some things that
went well?
b) What are somethings that were challenging?
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c) What is important to you in a health care visit and in a medical
provider?

d) What makes a good health care visit and provider to you?
e) How often have these expectations been met?
(ii) Some people report they may have urinary issues. For example:
going too frequently, weak stream, and urinary tract infection are
just a few. Have you had any bothersome urinary issues?
a) Are you satisﬁed with your urinary abilities as they are now?
b) Have you ever spoken to a doctor about these issues?
(i) No ! Did you want to? What prevented you from reaching out?
(ii) Yes ! Can we talk about what that experience was like?
(iii) May I ask you some questions about your sexual experiences with
others or by yourself? What is important for you sexually?
a) Some people report having sexual problems. For example: erectile or vaginal function issues, pain with sexual activity, or STIs.
Have you had any issues with your sexual ability?
(i) Pain with sexual activity ! Have you met with anyone to
help with the pain like a pelvic ﬂoor therapist?
(ii) Are you satisﬁed with your sexual ability/function?

b) Have you ever spoken to a doctor about this?
(i) No ! Did you want to? What prevented you from reaching
out?

(ii) Yes ! Can we talk about what that experience was like?
(iii) Is there anything else regarding your health care experiences/
urological care that you would like to share before we move
on?
(iv) Are there any other things that we might have missed that would be
important to include about your health care experiences? Are there
any other questions or comments?

Thank you for your time, this concludes our interview. I am
now going to turn off the recorder.
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APPENDIX 2: CODE BOOK
A Qualitative Study of the Transgender Patient Experience in the Urology Setting

No.
1
2
3
4

Code

Definition

Positive Experience with
Provider
Negative Experience with
Provider
Provider attitude

Use this code when respondent describes a positive experience with a health provider.

9

Patient provider
communication
Patient provider trust
Provider medical
knowledge
Provider cultural
competency
Patient Confidence in
Provider
Overall clinic experience

10

Barriers to Care

11

Patient provider priorities

12

Patient medical
knowledge

13

Conflicts between
treatments/priorities
and their side effects
Finding a “safe” provider
and space
Finding “knowledgeable”
provider
Educating the Medical
Office

5
6
7
8

14
15
16

17

Misgendered in health
care

18

20

Prior traumatic health
care experience
Prior traumatic
experience general
Health care anxiety

21

Care seeking

22

Urinary symptoms
treatment
Urinary symptoms other

19

23
24
25
26
27

Sexual symptoms
treatment
Sexual symptoms other
Physical exam
Desired provider and
health care visit
attributes

Use this code when respondent describes a negative experience with a health provider.
Use this code when respondent comments about a provider’s positive or negative attitude towards them during a
medical encounter.
Use this code when respondent describes positive or negative experiences communicating with providers or the health
clinic office. Includes conversations re: identity disclosure. Excludes provider attitude.
Use this code when the respondent describes their trust in their provider, in a positive or negative way.
Use this code when the respondent discusses provider’s medical knowledge related to trans-health. Include both
negative and positive reports.
Use this code when the respondent discusses provider’s competency in the social and cultural aspects of the
respondent’s identity. Include both negative and positive reports.
Use this code when the respondent describes either positive or negative confidence in a provider’s ability to care for
them.
Use this code when respondent describes experience engaging with health care staff not including the provider
(physicians, NPs, PAs) Include: phone conversations to health care office, staff nurses, etc. Also include any
references to the space or resources on site. Excludes experiences of misgendering.
Use this code when the respondent discusses any barriers access to care. Including, finances, difficulties with insurance,
geographical or transportation issues, patient wellness, and any reason given by the respondent delaying or not
seeking care. Excludes anxiety and prior negative experiences.
Use this code when the respondent reports a mismatch when it comes to what the patient wants as the outcome of
health management versus what the physician wants. Includes medication, surgery, and advice.
Use this code when the respondent discusses or refers to their medical knowledge or information obtained from
physicians, including unexpected side effects or outcomes. Includes situations where patients were confused about
medication use or purpose.
Use this code when the respondent expresses discordance between treatment or course of action and desires of the
respondent. Includes medication and side effects.
Use this code when respondent describes how they find a provider and/or health care space wherein they feel “safe”.
Excludes mention of medical knowledge level of provider.
Use this code when respondent discusses finding a provider with the knowledge and/or training related to a specific
medical issue. Includes gender affirmation surgeries and therapies.
Use this code when the participant reports feeling as if they had to educate the medical office (PCP, nurse, front desk,
etc) on the medical and social context related to their gender identity (this would include justifying treatment to
provider). Code can be used when the respondent reports not feeling like they have to educate the medical office as
well.
Use this code when the respondent reports being misgendered by any member of the health care staff at a hospital /
clinic, or with the insurance company. Excludes instances that the patient may feel misgendered in social settings.
Includes situations where the respondent’s sexual partner is misgendered as well, either in person or in conversation.
Use this code with the respondent reports a traumatic health care experience. Excludes experiences that are not in a
health care setting.
Use this code when the respondent reports trauma related to their identity (ie, rape, family issues). Excludes
experiences of trauma in a health care setting.
Use this code when respondent reports feelings of anxiety or stress when seeing a health care provider. Includes patient
-provider experience.
Use this code when respondent discusses symptoms or conditions as they relate to when and why they seek or do not
seek care. Including not feeling the need to seek care generally. Excludes mentions of logistical barriers.
Use this code when the respondent reports urinary symptoms directly related to medical and surgical treatment.
Use this code when the respondent reports other urinary symptoms not directly related to medical and surgical
treatment.
Use this code when the respondent reports symptoms with sexual function they believe are related to medical and
surgical treatment. Include incidence of STI.
Use this code when the respondent reports other sexual symptoms they believe are not related to medical and surgical
treatment. Include incidence of STI.
Use this code when the respondent provides positive or negative comments about physical exams.
Use this code when the respondent discusses what is important to them in a health care provider and visit experience.
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